Home Menu

Site Navigation



Parkinson's Disease Tulip

NeuroTalk Support Groups > > >

Study on new alpha-synuclein metabolizer, "SynuClean"

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 09-25-2018, 07:12 PM #1
dan1000 dan1000 is offline
Junior Member
  
Join Date: Jul 2016
Posts: 34
8 yr Member
dan1000 dan1000 is offline
Junior Member
 
Join Date: Jul 2016
Posts: 34
8 yr Member
Default Study on new alpha-synuclein metabolizer, "SynuClean"
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons | PNAS
dan1000 is offline   Reply With QuoteReply With Quote
 

Tags
alpha-synuclein, metabolizer, study, synuclean

« Previous Thread | Next Thread »
Thread Tools
Display Modes
Threaded Mode Threaded Mode

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Similar Threads
Thread Thread Starter Forum Replies Last Post
New study from OIST on the pathology caused by alpha synuclein dan1000 Parkinson's Disease 0 06-03-2017 08:08 PM
Can the antibiotics "Ceftin" or "Flagyl" cause a temporary spike in Small Fiber pain? Apollo Peripheral Neuropathy 2 05-01-2012 09:17 AM
So which "existing" diabetes drug turns the PGC-1 Alpha "Master Switch" back on? caldeerster Parkinson's Disease 22 07-13-2011 11:23 AM


All times are GMT -5. The time now is 09:53 PM.


Powered by vBulletin • Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise (Lite) - vBulletin Mods & Addons Copyright © 2025 DragonByte Technologies Ltd.
 

NeuroTalk Forums

Helping support those with neurological and related conditions.

 

All posts copyright their original authors.

The material on this site is for informational purposes only,
and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider.

Always consult your doctor before trying anything you read here.

Home